Histopathological parameters are insufficient predictors for the indiv
idual course of disease in bladder cancer patients. In the past decade
, however, other criteria have been developed as a possible prognostic
aid to a better disease management, such as expression of specific ce
ll surface antigens, DNA content? chromosomal aberrations, cell prolif
eration, tumor cell-associated antigens, angiogenesis, gene rearrangem
ents, and point mutations. Since most tumors of the bladder are carcin
omas and are associated with dedifferentiation and high metastatic cap
ability, we investigated whether reduced expression of so-called diffe
rentiation factors in combination with increased cell motility might b
e correlated with tumor progression.